BioLine Rx Ltd (XTAE:BLRX)
â‚Ş 0.066 -0.001 (-1.49%) Market Cap: 83.27 Mil Enterprise Value: 84.88 Mil PE Ratio: 0 PB Ratio: 2.54 GF Score: 0/100

Q3 2024 BioLine RX Ltd Earnings Call Transcript

Nov 25, 2024 / 01:30PM GMT
Release Date Price: â‚Ş0.075 (-13.79%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx third-quarter 2024 financial results conference call. (Operator Instructions)

I would now like to turn over the call to John Lacey, Head of Investor Relations and Corporate Communications. John, please go ahead.

John Lacey
BioLine RX Ltd - Head of Investor Relations & Corporate Communications

Thank you, operator. Welcome, everyone. Thank you for joining us on our third quarter 2024 results conference call. Earlier today, we issued a press release, a copy of which is available in the Investor Relations section of our website. It was also filed as a 6-K.

I'd like to remind you that certain statements we make during the call will be forward-looking. Because such statements deal with future events and are subject to many risks and uncertainties, actual results may differ materially from those in the forward-looking statements. For a full discussion of these risks and uncertainties, please review our annual report on Form 20-F and our quarterly reports on Form 6-K that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot